The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
Objectives. We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines i...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2019/2606808 |
id |
doaj-bc48b4fe7631471a886fc31d9521642d |
---|---|
record_format |
Article |
spelling |
doaj-bc48b4fe7631471a886fc31d9521642d2020-11-24T23:07:44ZengHindawi LimitedDisease Markers0278-02401875-86302019-01-01201910.1155/2019/26068082606808The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord StimulationPiotr Kamieniak0Joanna Bielewicz1Cezary Grochowski2Jakub Litak3Agnieszka Bojarska-Junak4Beata Daniluk5Tomasz Trojanowski6Department of Neurosurgery, Medical University of Lublin, PolandDepartment of Neurology, Medical University of Lublin, PolandDepartment of Neurosurgery, Medical University of Lublin, PolandDepartment of Neurosurgery, Medical University of Lublin, PolandDepartment of Clinical Immunology, Medical University of Lublin, PolandInstitute of Psychology, Marie Curie-Skłodowska University in Lublin, PolandDepartment of Neurosurgery, Medical University of Lublin, PolandObjectives. We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. Materials and Methods. Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. Results. We found a significant difference between the patients before SCS and controls’ serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls’ serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. Conclusions. SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity.http://dx.doi.org/10.1155/2019/2606808 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Piotr Kamieniak Joanna Bielewicz Cezary Grochowski Jakub Litak Agnieszka Bojarska-Junak Beata Daniluk Tomasz Trojanowski |
spellingShingle |
Piotr Kamieniak Joanna Bielewicz Cezary Grochowski Jakub Litak Agnieszka Bojarska-Junak Beata Daniluk Tomasz Trojanowski The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation Disease Markers |
author_facet |
Piotr Kamieniak Joanna Bielewicz Cezary Grochowski Jakub Litak Agnieszka Bojarska-Junak Beata Daniluk Tomasz Trojanowski |
author_sort |
Piotr Kamieniak |
title |
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_short |
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_full |
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_fullStr |
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_full_unstemmed |
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_sort |
elevated serum level of ifn-γ in patients with failed back surgery syndrome remains unchanged after spinal cord stimulation |
publisher |
Hindawi Limited |
series |
Disease Markers |
issn |
0278-0240 1875-8630 |
publishDate |
2019-01-01 |
description |
Objectives. We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. Materials and Methods. Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. Results. We found a significant difference between the patients before SCS and controls’ serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls’ serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. Conclusions. SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity. |
url |
http://dx.doi.org/10.1155/2019/2606808 |
work_keys_str_mv |
AT piotrkamieniak theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT joannabielewicz theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT cezarygrochowski theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT jakublitak theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT agnieszkabojarskajunak theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT beatadaniluk theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT tomasztrojanowski theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT piotrkamieniak elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT joannabielewicz elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT cezarygrochowski elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT jakublitak elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT agnieszkabojarskajunak elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT beatadaniluk elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT tomasztrojanowski elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation |
_version_ |
1725617322757980160 |